INTRODUCTION
Connective tissue disorders such as rheumatoid arthritis (RA)' or systemic lupus erythematosus (SLE) are characterized by histopathologic evidence of lymphocytic infiltrations within many of the basic tissue lesions. For well over a decade investigative focus in these disorders has revolved around description and characterization of tissue-reacting humoral antibodies and socalled autoantibodies as being important to the disease processes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Recently more attention (11) (12) (13) has been directed at cells prominently involved in the tissue lesions of RA and SLE-the lymphocytes-and their possible contribution to the pathogenesis of such connective tissue disorders. Immune lymphocytes have been characterized as belonging to two fundamental classes: (a) B-cells or lymphocytes bearing readily detectable surface immunoglobulin determinants and involved in the production of antibody and (b) T-cells derived from the thymus, bearing no readily detectable surface immunoglobulins and committed to cell-mediated immune reactions. Since little is understood of the precise effector systems involved in actual tissue destruction in patients with connective tissue disease, it seemed possible that a careful study of the peripheral blood and tissue distribution of T-cells and B-cells in these disorders might be illuminating. Clear-cut identification of peripheral blood B-cells is now possible through the use of specific immunofluorescent antisera to Ig and enu-
METHODS
Clinical material. 57 normal subj ects ranging in age from 21 to 50 yr provided the peripheral blood lymphocytes used in our studies. 70 patients with active RA and 24 with SLE were derived from the out-patient and inpatient populations of the Bernalillo County Hospital or Veterans Administration Hospital, Albuquerque, N. M. Clinical activity of disease in individual patients was graded from 1 + to 4 + on the basis of independent review of clinical records without concurrent knowledge of the results of the special studies done. American Rheumatism Criteria for clinical staging of RA were used; in addition the clinical activity of patients with SLE was recorded on the basis of degree and severity of system involvement along with results of laboratory indicators of disease activity such as serum complement activity, leukopenia, or microscopic examination of urine sediment.
Besides the normal subjects studied, a second control group of 21 patients under treatment for active pulmonary or disseminated tuberculosis was also included. The majority of these patients had active moderate or far-advanced tuberculous infection.
Finally, because the focus of the study involved attempts to ascertain possible subtle abnormalities in peripheral blood lymphocyte populations of patients with connective tissue diseases, a small group of five patients with Felty's syndrome associated with RA were also included.
Identification of B-cells in peripheral blood. Peripheral blood lymphocytes were collected from blood drawn in heparinized syringes and cells separated using a FicollHypaque gradient as previously described (31, 32 Fig. 3 . The mean value for percent T-cells in normals was 75.3±13.95.
Correlation between H-chain subclass and surface staining for K-or W-light chain determinants. As a check on the reliability of adding percentages of cells staining for vG, 'yA, yM together to obtain a figure for B-cells, patients' lymphocytes were also stained with fluoresceinated specific antibody of anti-K or anti-X activity, and sums of cells staining for YG, plus 'yA plus yM compared with those staining for K-plus X-determinants. Reasonably good correlation of these sums was obtained (Table IV) although values for K-plus X-staining were consistently slightly lower than figures for 'yA + aG + yM. No direct conclusion could be drawn from these observations but the slightly lower values for K plus X were consistent with the idea that a few B-cells might indeed contain more than one surface immunoglobulin marker.
Studies in patieints with RA. In general, mean values for percentages of B-cells as identified by the percentage of surface Ig containing cells were slightly lower in patients with RA than among the normal controls studied but these individual differences were not significant. (Table II) .
When the relative distribution and range of percentages of T-cells were examined among 41 patients with RA ( Fig. 3) (34) were carefully monitored in these same patients. It is important to note that this finding of an apparently large population of null cells not accounted for as B-or T-cells by the methods outlined here was not encountered among any normal subject studied.
The findings recorded here were felt to be compatible with the concept that in some patients with RA, a large population of the peripheral blood lymphocytes were somehow different and either as T-cells or B-cells showed diminished or altered reactivity in the test systems used. By contrast the total percentages of B-+ T-cells enumerated in normal controls similarly studied ranged from 70 to 119% with many patients showing sums extremely close to 100% (average 98.6%). Clear definition of the precise origin and derivation of the unaccounted for, or null, cells among the RA patients with low total sums of B-and T-cells must await more discriminating techniques than were available in the current study.
Felty's syndromc. All five patients with RA and Felty's syndrome showed relatively low total values for B-cells (range 6-16), mean 9.1% and high percentages of T-cells ranging from 85-96%. These latter data are shown as open circles in Fig. 3 .
Systemic lupus erythemnatosus. In all, 24 individuals were studied for percentage of peripheral blood lymphocytes as T-cells and in 21 individuals, data on T-cells plus B-cells were recorded. These findings are shown graphically in Fig. 3 and also in Table VII . As was noted among the group of patients with RA, in some 290 4 20 97 117 * Miliary tuberculosis. T-cell staining was performed in 10 normal subjects. In no instance was significant double staining documented confirming the idea that these methods in use for identifying T-cells and B-cells showed no detectable overlap.
Active tuberculosis. The data obtained on T-and B-cells among the 21 patients with active acid-fast infection are shown in Table VIII . Of great interest was the occurrence of a very low percent of identifiable T-cells in patient L. J., indicating that the latter phenomenon was not a feature peculiar to patients with connective tissue disease. No correlation between degree of disease activity or specific drug therapy and percentage of identifiable peripheral blood T-cells or B-cells was seen, except that the three patients with documented miliary tuberculosis 3 (V. S.), 5 (W. Y.), and 6 (R. L.), Table VIII, showed relatively low peripheral blood T-cell values. More extended serial observations on individual patients are necessary before this question can be completely settled.
DISCUSSION
The studies reported here provide an initial attempt to define peripheral blood and tissue distribution of T-cells and B-cells in patients with the connective tissue diseases such as RA or SLE. The major contribution outlined in the current report relates to the studies of peripheral blood lymphocytes using the rabbit antiserum which after appropriate absorption, appeared to show some degree of specificity for lymphocytes derived from or related to the T-cell system.
The most interesting finding uncovered during the present study lay in the finding that in certain patients with RA and SLE and occasionally in active tuberculous subjects there appeared to be a certain segment of the peripheral blood lymphocytes which were not readily identifiable by the methods used either as T-cells or B-cells. The exact identity of these null cells presents an intriguing question. Particularly in many instances of active RA these cells constituted as many as 48-79% of peripheral blood lymphocytes. In patients with extremely active RA a tendency for low levels of identifiable T-cells was noted, however, no direct correlations were possible between low T-cell percentages and clinical disease activity in patients with SLE. Three patients with miliary tuberculosis showed T-cell percentages at the lower range of values when compared with 18 subjects with other forms of active acid-fast infection. Currently studies are underway using the recently described sheep-cell rosette method for human Studies of T-and B-Lymphocytes in Connective Tissue Diseases 293 T-cell identification (38) (39) (40) to attempt to characterize the origin or type of null cell encountered in our studies to date. Preliminary data essentially using the technique described by Frdland (39) indicate that in normal subjects our T-cell direct ARAHT antiserum generally identifies considerably more (10-40%) peripheral blood lymphocytes than does the sheep-cell rosette technique. Further comparative work along these lines is certainly indicated.
The presence of either low or high percentages of B-cells bearing detectable surface Ig in the face of severe clinical lupus activity in several patients suggests that serial studies of B-cells and their turnover may relate such findings to changes in clinical activity. As mentioned above, the finding in some patients with SLE of lymphocytes bearing more than one detectable surface localized class of Ig does not imply that such Ig was all a product of these cells. Adherent A word of restraint is certainly indicated in an evaluation of our data and some of the general approaches outlined here, particularly with respect to whether or not CLL cells can be regarded or used as pure populations of B-cells as in the absorption experiments illustrated in Fig. 1 . Although the CLL cells used contained relatively high proportions of cells bearing surface Ig (80-95%), it is conceivable that such cells may contain cell-surface antigenic deletions related to the leukemic process itself. Other workers have encountered some degree of anomalous behavior when leukemic cells have been studied with standard anti-HL-A typing antisera (43) . Thus CLL cells may not be the ideal source of a B-cell population with which to absorb antihuman thymocyte antisera. Current studies are under way to define preparative methods by which B-cells may be harvested from normal human donors. The techniques recently described by Abdou (44) using columns of anti-Ig-coated beads may provide a practical solution to this problem.
Regardless of the theortic objections to the use of CLL cells in absorption of antithymocyte antisera, the results reported here would appear to indicate some degree of T-cell specificity obtained with the absorber rabbit antisera. The virtual 100% reactivity for fetal thymocytes, 42% activity against living human splenic lymphocytes, and 18% staining of B-cells would argue in favor of reactivity for antigens similar to the 0-system in mice. In addition, the absence of any evidence for double staining when rhodamine conjugates for anti-Ig and fluorescein-conjugated anti-T-cell markers were examined concurrently is a strong point in favor of the specificity of the approach outlined here..
For years investigators and clinicians alike have been enthralled by the myriad of autoantibodies demonstrable in the sera of patients with SLE and RA. The purpose of this report would be well served if now more attention were directed at the possible effector cellslymphocytes-in these disorders. Clinical examples of the potential importance of circulating lymphocytes have been recently reported in which a remission of severe active RA was produced through long-term lymphocyte depletion via thoracic duct drainage (45, 46) . A better definition and more precise insight into T-cell and B-cell kinetics and behavior may eventually provide us with considerable basic understanding of the connective tissue disease.
